These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 26854485)
1. Expression of the MOZ-TIF2 oncoprotein in mice represses senescence. Largeot A; Perez-Campo FM; Marinopoulou E; Lie-a-Ling M; Kouskoff V; Lacaud G Exp Hematol; 2016 Apr; 44(4):231-7.e4. PubMed ID: 26854485 [TBL] [Abstract][Full Text] [Related]
2. MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells. Perez-Campo FM; Costa G; Lie-A-Ling M; Stifani S; Kouskoff V; Lacaud G Stem Cells; 2014 Jun; 32(6):1591-601. PubMed ID: 24307508 [TBL] [Abstract][Full Text] [Related]
3. MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2. Yin H; Glass J; Blanchard KL Mol Cancer; 2007 Aug; 6():51. PubMed ID: 17697320 [TBL] [Abstract][Full Text] [Related]
4. A MOZ-TIF2 leukemia mouse model displays KAT6-dependent H3K23 propionylation and overexpression of a set of active developmental genes. Smolko AE; Sullivan DW; Olsen SN; Kang H; Whedon SD; Baell JB; Cole PA; Armstrong SA; Kuroda MI Proc Natl Acad Sci U S A; 2024 Jun; 121(26):e2405905121. PubMed ID: 38889153 [TBL] [Abstract][Full Text] [Related]
5. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion. Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712 [TBL] [Abstract][Full Text] [Related]
6. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway. Sheikh BN; Phipson B; El-Saafin F; Vanyai HK; Downer NL; Bird MJ; Kueh AJ; May RE; Smyth GK; Voss AK; Thomas T Oncogene; 2015 Nov; 34(47):5807-20. PubMed ID: 25772242 [TBL] [Abstract][Full Text] [Related]
9. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Liang J; Prouty L; Williams BJ; Dayton MA; Blanchard KL Blood; 1998 Sep; 92(6):2118-22. PubMed ID: 9731070 [TBL] [Abstract][Full Text] [Related]
10. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Deguchi K; Ayton PM; Carapeti M; Kutok JL; Snyder CS; Williams IR; Cross NC; Glass CK; Cleary ML; Gilliland DG Cancer Cell; 2003 Mar; 3(3):259-71. PubMed ID: 12676584 [TBL] [Abstract][Full Text] [Related]
11. STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2. Tam WF; Hähnel PS; Schüler A; Lee BH; Okabe R; Zhu N; Pante SV; Raffel G; Mercher T; Wernig G; Bockamp E; Sasca D; Kreft A; Robinson GW; Hennighausen L; Gilliland DG; Kindler T Cancer Res; 2013 Jan; 73(1):373-84. PubMed ID: 23149921 [TBL] [Abstract][Full Text] [Related]
12. Ring1A and Ring1B inhibit expression of Glis2 to maintain murine Shima H; Takamatsu-Ichihara E; Shino M; Yamagata K; Katsumoto T; Aikawa Y; Fujita S; Koseki H; Kitabayashi I Blood; 2018 Apr; 131(16):1833-1845. PubMed ID: 29371181 [TBL] [Abstract][Full Text] [Related]
13. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis. Katsumoto T; Yoshida N; Kitabayashi I Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862 [TBL] [Abstract][Full Text] [Related]